i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Receives FDA Fast Track Designation for Treatment of Ulcerative Pyoderma Gangrenosum

Jul 06, 2022

Time to read 4 Minutes

Download PDF

Back